Literature DB >> 7853980

Pituitary apoplexy after goserelin.

S Ando, T Hoshino, S Mihara.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7853980     DOI： 10.1016/s0140-6736(95)90443-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment.

Authors:  Georges Tanios; Nicolas Andrews Mungo; Aaysha Kapila; Kailash Bajaj
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Pituitary apoplexy after leuprolide.

Authors:  Anu Davis; Shefali Goel; Michalis Picolos; Min Wang; Victor Lavis
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.

Authors:  Y Reznik; F Chapon; N Lahlou; N Deboucher; J Mahoudeau
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

Review 4.  Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

Authors:  Yannis Guerra; Evelyn Lacuesta; Francisco Marquez; P B Raksin; Manuel Utset; Leon Fogelfeld
Journal:  Pituitary       Date:  2010       Impact factor: 4.107

5.  Clomiphene-induced pituitary apoplexy in a patient with acromegaly.

Authors:  A B Walker; P R Eldridge; I A MacFarlane
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

Review 6.  GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.

Authors:  Francisco J Guarda; Xiaoling Yu; Philip J Saylor; Lisa B Nachtigall; Naila Shiraliyeva; Melanie S Haines; Michael Bradbury
Journal:  Pituitary       Date:  2021-04-09       Impact factor: 4.107

7.  Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.

Authors:  Mariana Barbosa; Sílvia Paredes; Maria João Machado; Rui Almeida; Olinda Marques
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-06-04

8.  Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up.

Authors:  Belal Aljabri; Wolfgang Lilleby; Marta D Switlyk; Gunnar Tafjord
Journal:  Urol Case Rep       Date:  2021-03-23

9.  Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.

Authors:  Tsung-Yi Huang; Jih-Pin Lin; Ann-Shung Lieu; Yi-Ting Chen; Hung-Sheng Chen; Mei-Yu Jang; Jung-Tsung Shen; Wen-Jeng Wu; Shu-Pin Huang; Yung-Shun Juan
Journal:  World J Surg Oncol       Date:  2013-10-02       Impact factor: 2.754

10.  Gonadotropin-releasing hormone agonist-induced pituitary apoplexy.

Authors:  Fergus Keane; Aoife M Egan; Patrick Navin; Francesca Brett; Michael C Dennedy
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.